Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Depress Anxiety. 2019 Apr 8;36(6):565–575. doi: 10.1002/da.22892

Table 2a:

Odds of being in each trajectory group, compared to the odds of being in the minimal symptoms group (reference category), per standard deviation increase in relative telomere length (cases and controls, n=8801).

Depressive Symptom Trajectory Group Age-only adjusted Odds Ratio 95% CI P-Value Adjusted Odds Ratio* 95% CI P-Value
Minimal Symptoms (n=5456) Ref Ref Ref Ref Ref Ref
Improving Symptoms (1672) 1.10 (0.91, 1.34) 0.32 1.10 (0.90,1.34) 0.36
Worsening Symptoms (n=1232) 0.69 (0.55, 0.86) 0.001 0.78 (0.62, 0.97) 0.02
Persistent Symptoms (n=441) 0.95 (0.71, 1.27) 0.72 1.02 (0.76, 1.37) 0.89

Adjusted for case/control status, pack years of smoking, BMI, antidepressant use, alcohol consumption, physical activity (MET hours/week), menopausal & hormone replacement therapy status, Charlson Index score, and paternal age at birth. Cases and controls were from nested case-control studies of various diseases in the Nurses’ Health Study blood cohort.